511 related articles for article (PubMed ID: 25549531)
1. Evaluating iatrogenic prescribing: development of an oncology-focused trigger tool.
Hébert G; Netzer F; Ferrua M; Ducreux M; Lemare F; Minvielle E
Eur J Cancer; 2015 Feb; 51(3):427-35. PubMed ID: 25549531
[TBL] [Abstract][Full Text] [Related]
2. Performance of the adverse drug event trigger tool and the global trigger tool for identifying adverse drug events: experience in a Belgian hospital.
Carnevali L; Krug B; Amant F; Van Pee D; Gérard V; de Béthune X; Spinewine A
Ann Pharmacother; 2013 Nov; 47(11):1414-9. PubMed ID: 24285758
[TBL] [Abstract][Full Text] [Related]
3. Development of a 'ready-to-use' tool that includes preventability, for the assessment of adverse drug events in oncology.
Hébert G; Netzer F; Kouakou SL; Lemare F; Minvielle E;
Int J Clin Pharm; 2018 Apr; 40(2):376-385. PubMed ID: 29446003
[TBL] [Abstract][Full Text] [Related]
4. Adverse drug events in critically ill patients with cancer: incidence, characteristics, and outcomes.
Nazer LH; Hawari F; Al-Najjar T
J Pharm Pract; 2014 Apr; 27(2):208-13. PubMed ID: 24319079
[TBL] [Abstract][Full Text] [Related]
5. The Adverse Drug Event Collaborative: a joint venture to measure medication-related patient harm.
Seddon ME; Jackson A; Cameron C; Young ML; Escott L; Maharaj A; Miller N
N Z Med J; 2012 Jan; 126(1368):9-20. PubMed ID: 23385830
[TBL] [Abstract][Full Text] [Related]
6. A targeted method for standardized assessment of adverse drug events in surgical patients.
de Boer M; Kiewiet JJ; Boeker EB; Ramrattan MA; Dijkgraaf MG; Lie-A-Huen L; Boermeester MA;
J Eval Clin Pract; 2013 Dec; 19(6):1073-82. PubMed ID: 23593984
[TBL] [Abstract][Full Text] [Related]
7. Development, testing, and findings of a pediatric-focused trigger tool to identify medication-related harm in US children's hospitals.
Takata GS; Mason W; Taketomo C; Logsdon T; Sharek PJ
Pediatrics; 2008 Apr; 121(4):e927-35. PubMed ID: 18381521
[TBL] [Abstract][Full Text] [Related]
8. Adverse drug events identified by triggers at a teaching hospital in Brazil.
Giordani F; Rozenfeld S; Martins M
BMC Pharmacol Toxicol; 2014 Dec; 15():71. PubMed ID: 25496209
[TBL] [Abstract][Full Text] [Related]
9. Adverse drug event detection in pediatric oncology and hematology patients: using medication triggers to identify patient harm in a specialized pediatric patient population.
Call RJ; Burlison JD; Robertson JJ; Scott JR; Baker DK; Rossi MG; Howard SC; Hoffman JM
J Pediatr; 2014 Sep; 165(3):447-52.e4. PubMed ID: 24768254
[TBL] [Abstract][Full Text] [Related]
10. Adverse drug event nonrecognition in emergency departments: an exploratory study on factors related to patients and drugs.
Roulet L; Ballereau F; Hardouin JB; Chiffoleau A; Potel G; Asseray N
J Emerg Med; 2014 Jun; 46(6):857-64. PubMed ID: 24565882
[TBL] [Abstract][Full Text] [Related]
11. Testing a trigger tool as a method of detecting harm from medication errors in a UK hospital: a pilot study.
Franklin BD; Birch S; Schachter M; Barber N
Int J Pharm Pract; 2010 Oct; 18(5):305-11. PubMed ID: 20840687
[TBL] [Abstract][Full Text] [Related]
12. Establishment of a pediatric trigger tool based on Global Trigger Tool to identify adverse drug events of children: experience in a Chinese hospital.
Liu Y; Yan J; Xie Y; Bian Y
BMC Pediatr; 2020 Sep; 20(1):454. PubMed ID: 32993580
[TBL] [Abstract][Full Text] [Related]
13. Hospital admissions caused by adverse drug events: an Australian prospective study.
Phillips AL; Nigro O; Macolino KA; Scarborough KC; Doecke CJ; Angley MT; Shakib S
Aust Health Rev; 2014 Feb; 38(1):51-7. PubMed ID: 24351707
[TBL] [Abstract][Full Text] [Related]
14. The risk of adverse drug events and hospital-related morbidity and mortality among older adults with potentially inappropriate medication use.
Page RL; Ruscin JM
Am J Geriatr Pharmacother; 2006 Dec; 4(4):297-305. PubMed ID: 17296535
[TBL] [Abstract][Full Text] [Related]
15. Adverse Drug Event Rate in Israeli Hospitals: Validation of an International Trigger Tool and an International Comparison Study.
Zimlichman E; Gueta I; Daliyot D; Ziv A; Oberman B; Hochman O; Tamir O; Tal O; Loebstein R
Isr Med Assoc J; 2018 Nov; 20(11):665-669. PubMed ID: 30430793
[TBL] [Abstract][Full Text] [Related]
16. Validating the Chinese geriatric trigger tool and analyzing adverse drug event associated risk factors in elderly Chinese patients: A retrospective review.
Hu Q; Qin Z; Zhan M; Chen Z; Wu B; Xu T
PLoS One; 2020; 15(4):e0232095. PubMed ID: 32343726
[TBL] [Abstract][Full Text] [Related]
17. Establishing a trigger tool based on global trigger tools to identify adverse drug events in obstetric inpatients in China.
Wu S; Yin Q; Wu L; Wu Y; Yu N; Yan J; Bian Y
BMC Health Serv Res; 2024 Jan; 24(1):72. PubMed ID: 38225629
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for hospital admissions associated with adverse drug events.
Kongkaew C; Hann M; Mandal J; Williams SD; Metcalfe D; Noyce PR; Ashcroft DM
Pharmacotherapy; 2013 Aug; 33(8):827-37. PubMed ID: 23686895
[TBL] [Abstract][Full Text] [Related]
19. Adverse drug event-related emergency department visits associated with complex chronic conditions.
Feinstein JA; Feudtner C; Kempe A
Pediatrics; 2014 Jun; 133(6):e1575-85. PubMed ID: 24843054
[TBL] [Abstract][Full Text] [Related]
20. Adverse drug events are a major cause of acute medical admission.
McLachlan CY; Yi M; Ling A; Jardine DL
Intern Med J; 2014 Jul; 44(7):633-8. PubMed ID: 24750276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
